{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:08:50Z","timestamp":1753891730328,"version":"3.41.2"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Since the first case of Guillain-Barr\u00e9 syndrome (GBS)-associated SARS-CoV-2 (COVID-19) infection reported in 2020, a series of cases have been published in some countries. In this case report, we present a young patient with GBS, whose clinical and laboratory data were appropriate for the diagnosis of GBS due to COVID-19 infection. Neurological examination revealed the muscular weakness of lower limbs with Medical Research Council (MRC) scale of 2\/5 associated with diminished reflexes. Laboratory studies showed the positive nasal swab RT-PCR test for COVID-19, leukopenia, increased ferritin and LDH levels, normal electrolyte and liver and kidney function, and normal chest X-ray. The result of cerebrospinal fluid showed the albuminocytologic dissociation. The patient was treated with remdesivir, dexamethasone, anticoagulation, and therapeutic plasma exchange (TPE). Patient's muscle weakness was significantly improved after 1 week of admission. He was discharged at 23rd days of hospitalization and followed-up in the out-patients department.<\/jats:p>","DOI":"10.3389\/fneur.2022.868667","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T09:43:52Z","timestamp":1653471832000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Guillain-Barr\u00e9 Syndrome in Patient With SARS-CoV-2 PCR Positivity Treated Successfully With Therapeutic Exchange Plasma: A First Case Report From Vietnam"],"prefix":"10.3389","volume":"13","author":[{"given":"Sy","family":"Duong-Quy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duc","family":"Huynh-Truong-Anh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thanh","family":"Nguyen-Thi-Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tien","family":"Nguyen-Quang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thanh","family":"Nguyen-Chi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quynh","family":"Tran-Xuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinh","family":"Nguyen-Nhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carine","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Craig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40120-020-00225-0","article-title":"Sars-Cov-2 infection: symptoms of the nervous system and implications for therapy in neurological disorders","volume":"23","author":"Losy","year":"2020","journal-title":"Neurol Ther."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e1060","DOI":"10.1212\/WNL.0000000000009937","article-title":"Neurologic manifestations in hospitalized patients with Covid-19: the albacovid registry","volume":"95","author":"Romero-S\u00e1nchez","year":"2020","journal-title":"Neurology."},{"key":"B3","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S1474-4422(20)30109-5","article-title":"Chen S. Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection: causality or coincidence?","volume":"19","author":"Zhao","year":"2020","journal-title":"Lancet Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s13365-020-00884-7","article-title":"Severe rapidly progressive Guillain-Barr\u00e9 syndrome in the setting of acute COVID-19 disease","volume":"26","author":"Abrams","year":"2020","journal-title":"J Neurovirol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.7759\/cureus.21246","article-title":"Post SARS-CoV-2 Guillain-Barr\u00e9 syndrome: case report","volume":"131","author":"Arnaud","year":"2020","journal-title":"Clin Neurophysiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1007\/s10072-020-04484-5","article-title":"New clinical manifestation of COVID-19 related Guillain-Barr\u00e8 syndrome highly responsive to intravenous immunoglobulins: two Italian cases","volume":"41","author":"Assini","year":"2020","journal-title":"Neurol Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.bbi.2020.04.074","article-title":"Guillain-Barr\u00e9 syndrome as a complication of SARS-CoV-2 infection","volume":"87","author":"Coen","year":"2020","journal-title":"Brain Behav Immun."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.602554","article-title":"Case report: postacute rehabilitation of Guillain-Barr\u00e9 syndrome and cerebral vasculitis-like pattern accompanied by SARS-CoV-2 infection","author":"Colonna","year":"2021","journal-title":"Front Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-barr\u00e9 syndrome","volume":"388","author":"Wilison","year":"2016","journal-title":"Lancet."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e196","DOI":"10.1002\/ccr3.5638","article-title":"Guillain-barr\u00e9 syndrome associated with the coronavirus disease 2019 (COVID-19)","volume":"11","author":"Ebrahimzadeh","year":"2021","journal-title":"Neurol Clin Pract."},{"key":"B11","doi-asserted-by":"publisher","first-page":"577294","DOI":"10.1016\/j.jneuroim.2020.577294","article-title":"Guillain-Barr\u00e9 syndrome in a patient infected with SARS-CoV-2, a case report","volume":"346","author":"Farzia","year":"2020","journal-title":"J Neuroimmunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e239218","DOI":"10.1136\/bcr-2020-239218","article-title":"Guillain-Barr\u00e9 syndrome after COVID-19 in Japan","volume":"13","author":"Hirayama","year":"2020","journal-title":"BMJ Case Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1111\/ene.14398","article-title":"Guillain Barr\u00e9 syndrome after SARS-CoV-2 infection","volume":"27","author":"Kilinc","year":"2020","journal-title":"Eur J Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e237215","DOI":"10.1136\/bcr-2020-237215","article-title":"Guillain-Barr\u00e9 syndrome associated with COVID-19 disease","volume":"13","author":"Korem","year":"2020","journal-title":"BMJ Case Rep."},{"key":"B15","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/mus.27024","article-title":"COVID-19 \u2013 associated Guillain-Barr\u00e9 syndrome: the early pandemic experience","volume":"62","author":"Caress","year":"2020","journal-title":"Muscle Nerve."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s00415-020-10124-x","article-title":"Guillain-Barr\u00e9 syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases","volume":"268","author":"Rumeileh","year":"2021","journal-title":"J Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"6045","DOI":"10.1002\/jmv.27159","article-title":"COVID-19-associated Guillain-Barr\u00e9 syndrome: postinfectious alone or neuroinvasive too?","volume":"93","author":"Khan","year":"2021","journal-title":"J Med Virol."},{"key":"B18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0140-6736(96)09095-2","article-title":"Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barr\u00e9 syndrome","volume":"349","author":"Plasma","year":"1997","journal-title":"Lancet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"CD001798","DOI":"10.1002\/14651858.CD001798.pub3","article-title":"Plasma exchange for Guillain-Barr\u00e9 syndrome","volume":"7","author":"Raphael","year":"2012","journal-title":"Cochrane Database Syst Rev."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1111\/trf.16218","article-title":"Therapeutic plasma exchange for COVID-19-asociated hyperviscosity","volume":"61","author":"Truong","year":"2020","journal-title":"Transfusion."},{"key":"B21","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1136\/jnnp-2016-314862","article-title":"Treatment dilemmas in Guillain-Barr\u00e9 syndrome","volume":"88","author":"Verboon","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B22","doi-asserted-by":"publisher","first-page":"102920","DOI":"10.1016\/j.amsu.2021.102920","article-title":"Therapeutic plasma exchange in COVID-19 pnemonia in intensive care unit: cases series","volume":"71","author":"Zaid","year":"2021","journal-title":"Ann Med Surg (Lond)."},{"key":"B23","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/vox.13067","article-title":"Understanding the role of therapeutic plasma exchange in COVID-19: preliminary guidance and practices","volume":"116","author":"Patidar","year":"2021","journal-title":"Vox Sanguinis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1093\/brain\/awab066","article-title":"Spanish Investigators on Emergency Situations TeAm (SIESTA) network. Currently available data regarding the potential association between COVID-19 and Guillain-Barr\u00e9 syndrome","volume":"144","author":"Gonz\u00e1lez Del Castillo","year":"2021","journal-title":"Brain."},{"key":"B25","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1093\/brain\/awab279","article-title":"IGOS consortium. Guillain-Barr\u00e9 syndrome after SARS-CoV-2 infection in an international prospective cohort study","volume":"144","author":"Luijten","year":"2021","journal-title":"Brain."},{"key":"B26","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1093\/brain\/awaa433","article-title":"Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barr\u00e9 syndrome","volume":"144","author":"Keddie","year":"2021","journal-title":"Brain"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.868667\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T09:43:55Z","timestamp":1653471835000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.868667\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,25]]},"references-count":26,"alternative-id":["10.3389\/fneur.2022.868667"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.868667","relation":{},"ISSN":["1664-2295"],"issn-type":[{"type":"electronic","value":"1664-2295"}],"subject":[],"published":{"date-parts":[[2022,5,25]]},"article-number":"868667"}}